From Model to Molecule: Rapid Discovery of Potent CDK2 Inhibitors Using Boltz-2

Published: 25 Mar 2026, Last Modified: 04 May 2026AI4X-AC 2026 OralEveryoneRevisionsBibTeXCC BY 4.0
Submission Type: I want my submission to be considered for both oral and poster presentation.
Keywords: Drug Discovery, Structure-Based Drug Design, Cyclin-Dependent Kinase, Artificial Intelligence
TL;DR: Boltz-2 enables a closed-loop computational–experimental workflow that translates large-scale virtual screening into experimentally validated CDK2 inhibitors.
Confirmation Of Submission Requirements: I submit an abstract. It uses the template provided on the submission page and is no longer than 2 pages.
PDF: pdf
Submission Number: 382
Loading